Zymeworks Signs Roche Cancer-Drug Deal Worth Up to $813 Million
Roche agrees to license Zymeworks’ experimental ZW209 cancer treatment for $55 million upfront, with further payments tied to development and commercial milestones.
Latest Posts
Booz Allen Raises Earnings Outlook Despite Revenue Decline
Booz Allen raises its fiscal 2027 adjusted earnings outlook after stronger quarterly profit, while revenue falls and cash flow remains below last year’s level.
SLB Revenue Rises to $9.45 Billion as Data Center Business Expands
SLB reports higher third-quarter revenue and $828 million in free cash flow as oilfield activity improves, while its data center business adds a separate growth driver.
Munich Re Raises 2026 Profit Target to €6.6 Billion
Munich Re lifts its full-year profit forecast after preliminary third-quarter earnings of about €1.7 billion exceeded expectations, helped by lower major claims.
Sign up for
Newsletters
Nvidia’s AI Financing Faces Test as Neoclouds Sell Off
Nvidia’s cloud-capacity commitments and conditional guarantees face scrutiny as CoreWeave and other neoclouds suffer a selloff.
American Express to Cut 5% of Jobs as It Prepares for AI
American Express plans to cut about 5% of its workforce as it prepares for AI, joining Barclays and Netflix in a broader push to reshape staffing.
Ronaldo Is First Active Athlete to Earn $2 Billion, Forbes Says
Forbes estimates Ronaldo has surpassed $2 billion in career pretax earnings and projects $300 million this season, distinct from his $1.2 billion net worth.
Gold Falls Below $4,000 as Oil Fuels Fed Rate Concerns
Gold touched $3,986.50 before recovering above $4,000 as oil-driven inflation fears and Fed rate expectations kept bullion under pressure.
British Retail Sales Fall 0.4% as Warm Weather Hits Clothing
British retail volumes fell 0.4% in September as clothing and supermarket sales weakened, although sales still rose 0.7% across the third quarter.
Newmont Posts $2.20 Adjusted EPS as Cash Flow Fuels Buybacks
Newmont generates $1.9 billion in quarterly free cash flow, maintains its gold-output target and reports $2.8 billion remaining under its buyback program.
a16z Crypto Rebrands as Frontier, Expands Into AI and More
Chris Dixon confirms a16z Crypto is becoming a16z Frontier, broadening its investment remit while maintaining its commitment to crypto and existing portfolio companies.
Central Bank Gold Buying Tops Four Times Pre-2022 Pace
Goldman estimates central banks bought 79 tonnes of gold in August, while Dutch and French reserve changes highlight a renewed focus on storage and access.
CrowdStrike Stock Rises as NVIDIA Expands AI Agent Security Partnership
CrowdStrike shares rise as Falcon Guardian integrates with NVIDIA OpenShell, with a planned Sentry connection extending AI-agent security to hardware enforcement.